Cristina Becchimanzi

Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey

Corrado Girmenia, Alice Bertaina, Alfonso Piciocchi et al. · Clinical Infectious Diseases · 2017 · 160 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

RD‐CODOX‐M/IVAC with rituximab and intrathecal liposomal cytarabine in adult Burkitt lymphoma and ‘unclassifiable’ highly aggressive B‐cell lymphoma

Gaetano Corazzelli, Ferdinando Frigeri, Filippo Russo et al. · British Journal of Haematology · 2011 · 77 citations

Medicine, Oncology, Pharmacotherapy +17

Long-term results of gemcitabine plus oxaliplatin with and without rituximab as salvage treatment for transplant-ineligible patients with refractory/relapsing B-cell lymphoma

Gaetano Corazzelli, Gaetana Capobianco, Manuela Arcamone et al. · Cancer Chemotherapy and Pharmacology · 2009 · 76 citations

Medicine, Oncology, Pharmacology +14

Biweekly rituximab, cyclophosphamide, vincristine, non‐pegylated liposome‐encapsulated doxorubicin and prednisone (R‐COMP‐14) in elderly patients with poor‐risk diffuse large B‐cell lymphoma and moderate to high ‘life threat’ impact cardiopathy

Gaetano Corazzelli, Ferdinando Frigeri, Manuela Arcamone et al. · British Journal of Haematology · 2011 · 58 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +10

T cells from paroxysmal nocturnal haemoglobinuria (PNH) patients show an altered CD40-dependent pathway

Giuseppe Terrazzano, Michela Sica, Cristina Becchimanzi et al. · Journal of Leukocyte Biology · 2005 · 19 citations

Life Sciences, Hematology, Immunology +13